TNFRSF11A and multiple sclerosis: There is increasing evidence in other autoimmune diseases (multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease) that the RANKL/RANK pathway is involved in the induction of a proinflammatory phenotype of immune cells and exacerbation of the disease (73–78).